| 603538 | 美诺华 | -5.28 | 13.44 | -7141.76 | | --- | --- | --- | --- | --- | | 000953 | 河化股份 | 1.00 | 21.58 | -6783.63 | | 688222 | 成都先导 | -3.49 | 6.59 | -6676.58 | | 300363 | 博腾股份 | -1.62 | 4.18 | -6054.08 | | 600196 | 复星医药 | -0.98 | 1.29 | -5749.1 1 | | 688185 | 康希诺 | -2.80 | 5.15 | -5649.33 | | 688131 | 皓元医药 | -2.95 | 3.76 | -5426.18 | | 300683 | 海特生物 | -3.97 | 13.76 | -5362.08 | | 688553 | 汇宇制药 | -1.87 | 2.83 | -5128.77 | | 301096 | 百诚医药 | -2.81 | 6.89 | -4796.39 | | 300149 | 睿智医药 | -1.65 | 8.06 | -3859. ...

Group 1 - The A-share market's CRO sector experienced a collective pullback, with several companies showing significant declines [1] - HaiTe Bio fell over 6%, while MediSci, Nossger, Hongbo Pharmaceutical, Lianhua Technology, Chengdu XianDao, WuXi AppTec, Zhaoyan New Drug, and Haoyuan Medicine all dropped more than 3% [1]

证券之星消息，8月5日农化制品板块较上一交易日上涨0.34%，丰山集团领涨。当日上证指数报收于 3617.6，上涨0.96%。深证成指报收于11106.96，上涨0.59%。农化制品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 603810 | 丰山集团 | 17.27 | 3.85% | 3.14万 | 5362.57万 | | 002734 | 利民股份 | 21.88 | 2.87% | 59.84万 | 12.96ZZI | | 000422 | 湖北宣化 | 13.54 | 2.19% | 27.13万 | 3.63亿 | | 000902 | 新洋丰 | 14.40 | 1.91% | 10.80万 | 1.55亿 | | 300387 | 富邦科技 | 9.54 | 1.81% | 9.53万 | 9061.10万 | | 002545 | 东方铁塔 | 9.86 | 1.75% | 11.65万 | 1.15亿 | | 002470 | 金正大 | 1.7 ...

Group 1 - The latest stock price of Lianhua Technology is 11.10 yuan, an increase of 0.05 yuan from the previous trading day [1] - The stock opened at 10.99 yuan, reached a high of 11.38 yuan, and a low of 10.53 yuan, with a total trading volume of 1.5891 million hands and a transaction amount of 1.742 billion yuan [1] - On August 4, the stock experienced a rapid rebound, with a more than 2% increase within 5 minutes, reaching a price of 11.18 yuan and a transaction amount of 938 million yuan [1] Group 2 - Lianhua Technology's main business includes the research and production of pesticides and pharmaceutical intermediates, with applications in agriculture and medicine [1] - The company operates in sectors including pesticides, veterinary drugs, and Contract Research Organizations (CRO) [1] Group 3 - On the same trading day, the net outflow of main funds was 83.5027 million yuan, accounting for 0.83% of the circulating market value [1] - Over the past five trading days, there has been a cumulative net inflow of 143 million yuan, representing 1.42% of the circulating market value [1]

Core Viewpoint - Lianhua Technology (002250) has shown significant financial growth in the first quarter of 2025, with a notable increase in net profit and a strong performance in stock trading [1][2]. Financial Performance - As of the first quarter of 2025, the company reported total revenue of 1.51 billion yuan, representing a year-on-year growth of 3.02% [1]. - The net profit attributable to shareholders reached 49.72 million yuan, marking a substantial year-on-year increase of 1,747.04% [1]. - The company's non-recurring net profit was 47.79 million yuan, which is a year-on-year growth of 318.63% [1]. - Key financial ratios include a current ratio of 1.297, a quick ratio of 0.738, and a debt-to-asset ratio of 49.96% [1]. Stock Market Activity - On August 1, 2025, Lianhua Technology's stock closed at 11.05 yuan, up by 6.76% with a turnover rate of 18.96% [1]. - The trading volume was 1.719 million hands, with a total transaction value of 1.888 billion yuan [1]. - The net inflow of main funds was 110 million yuan, accounting for 5.82% of the transaction value [1]. Company Background - Lianhua Technology Co., Ltd. was established in 1998 and is located in Taizhou, primarily engaged in the manufacturing of chemical raw materials and products [2]. - The company has a registered capital of 911.33 million yuan, which is also its paid-in capital [1][2]. - The legal representative of the company is Wang Ping [1]. Investment and Intellectual Property - Lianhua Technology has made investments in 21 companies and participated in 37 bidding projects [2]. - The company holds 118 trademark registrations and 93 patents, along with 46 administrative licenses [2].

金融界消息 截至2025年7月29日收盘，联化科技（002250）报收于10.48元，上涨0.96%，换手率 7.88%，成交量71.46万手，成交金额7.35亿元。 资金流向方面，今日主力资金净流入2088.82万元，占比成交额2.84%。其中，超大单净流入455.59万 元、占成交额0.62%，大单净流入1633.23万元、占成交额2.22%，中单净流出流出1827.67万元、占成交 额2.49%，小单净流出261.15万元、占成交额0.36%。 天眼查商业履历信息显示，联化科技股份有限公司，成立于1998年，位于台州市，是一家以从事化学原 料和化学制品制造业为主的企业。企业注册资本91133.3117万人民币，实缴资本91133.3117万人民币。 公司法定代表人为王萍。 通过天眼查大数据分析，联化科技股份有限公司共对外投资了21家企业，参与招投标项目37次，知识产 权方面有商标信息118条，专利信息93条，此外企业还拥有行政许可46个。 来源：金融界 联化科技最新一期业绩显示，截至2025一季报，公司营业总收入15.10亿元、同比增长3.02%，归属净利 润4971.56万元，同比增长1747.04% ...

证券代码：002250 证券简称：联化科技 公告编号：2025-034 联化科技股份有限公司 2024 年度权益分派实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、根据《中华人民共和国公司法》（以下简称"《公司法》"）的规定，联化 科技股份有限公司（以下简称"公司"）回购专用证券账户持有的11,459,900股不 享有参与本次权益分派的权利。本次权益分派方案为：以公司现有总股本剔除已 回购股份11,459,900股后的899,873,217股为基数，向全体股东每10股派0.20元（含 税）。 2、根据2024年度权益分派方案，公司本次实际现金分红的总金额=实际参与 分配的总股本×分配比例，即17,997,464.34元=899,873,217股/10×0.20元/股。因 公司回购专用证券账户所持股份不参与现金分红，本次权益分派实施后，根据股 票市值不变原则，实施权益分派前后公司总股本保持不变，现金分红总额分摊到 每一股的比例将减小，因此，本次权益分派实施后除权除息价格计算时，每股现 金红利应以0.0197485元/股计算（每股现金红利 ...

Group 1 - The CRO concept sector experienced a decline of 0.53%, ranking among the top declines in concept sectors, with leading decliners including Lianhua Technology, Shengnuo Biology, and Meinuo Pharma [1][2] - Among the 24 stocks that rose, Sichuan Shuangma, Hanyu Pharmaceutical, and Meihao Medical had the highest increases of 3.14%, 1.98%, and 1.75% respectively [1][4] - The CRO concept sector saw a net outflow of 863 million yuan from major funds, with 47 stocks experiencing net outflows, and five stocks seeing outflows exceeding 30 million yuan [2][3] Group 2 - Lianhua Technology had the largest net outflow of major funds at 436 million yuan, followed by Ruizhi Pharmaceutical, WuXi AppTec, and Meinuo Pharma with outflows of 85 million yuan, 75 million yuan, and 48 million yuan respectively [2][3] - The stocks with the highest net inflows included Hanyu Pharmaceutical, Kailai Ying, and Sichuan Shuangma, with inflows of 37 million yuan, 17 million yuan, and 11 million yuan respectively [2][4] - The trading volume for Lianhua Technology was notably high at 21.98%, indicating significant trading activity despite the decline [3]

Core Viewpoint - Lianhua Technology experienced a significant drop in stock price, reaching the daily limit down, with a trading volume of 2.335 billion yuan and a turnover rate of 20.81% [2] Trading Activity - The stock was listed on the Dragon and Tiger list due to a daily decline of 10.03%, with net purchases from the Shenzhen Stock Connect amounting to 8.8277 million yuan and net sales from brokerage seats totaling 1.52 billion yuan [2] - The top five brokerage seats accounted for a total trading volume of 379 million yuan, with buying transactions of 118 million yuan and selling transactions of 261 million yuan, resulting in a net selling of 143 million yuan [2] - The largest buying brokerage was the Shenzhen Stock Connect, with a buying amount of 31.1602 million yuan and a selling amount of 22.3325 million yuan, leading to a net purchase of 8.8277 million yuan [3] Fund Flow - The stock saw a net outflow of 396 million yuan in main funds today, with a significant outflow of 305 million yuan from large orders and 90.5853 million yuan from big orders [3] - Over the past five days, the main funds experienced a net outflow of 389 million yuan [3] - As of June 17, the margin trading balance for the stock was 784 million yuan, with a financing balance of 782 million yuan and a securities lending balance of 2.1546 million yuan [3] - The financing balance increased by 106 million yuan over the past five days, representing a growth of 15.62%, while the securities lending balance decreased by 16.90 thousand yuan, a decline of 7.27% [3]

Group 1 - The core viewpoint of the article highlights a significant decline in pesticide stocks, with specific companies like Sulih Holdings and Lianhua Technology experiencing a trading halt due to a drop in share prices [1] - The article notes that several other companies in the pesticide sector, including Guangkang Biochemical, Meibang Co., Taihe Co., and Lanfeng Biochemical, saw their stock prices fall by over 5% [1] - Additional companies such as Zhongqi Co. and Hailier also experienced declines, indicating a broader trend of falling stock prices within the pesticide industry [1]